Publications 1999

  1. 36 Month Intermittent Cyclical Etidronate Treatment in Patients with Established Corticosteroid Induced Osteoporosis. J Rheumatol 1999;26(7):1545-1549. Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, Gordon M, Kaminska E, Scocchia T, Petrie A, Stephenson GF, Goldsmith CH
  2. 1998 Clinical Practice Guidelines for the Management of Diabetes in Canada. Can Med Assoc J. 1998;159(suppl):S1-S29. Meltzer S, Leiter L, Daneman D et al.
  3. A Comparison of Thoracic and Lumbar Epidural Techniques for Post-thoracoabdominal Esosphagectomy Analgesia. Can J Anaesth 1999;46)(5 Pt 1):415-422. Kahn L, Baxter FJ, Dauphin A, Goldsmith CH, Jackson PA, McChesney J, Miller JD, Takeuchi HL, Young JE
  4. A Paper Highlighting Discussion from a Forum On: Optimal Drug Therapy. Dated November 17, 1999 Summary PDF
  5. Access to Medical and Health Information in the Developing World: An essential tool for change in medical education C.M.A.J., 160(1):63-64, 1999 Haddad, H., MacLeod, S.M.
  6. Advancing the Measurement of Quality of Therapy Using Electronic Medical Records TEPR 1999Conference Proceedings Vol. 1 848-855. Holbrook AM, Keshavjee KK, Goldsmith C, Tucker T, Park L.
  7. Are Health States Timeless? The case of standard gamble method. Journal of Clinical Epidemiology 1999 Nov;52(11):1047-53. Bala M, Wood L, Zarkin G, Norton E, Gafni A, O'Brien B.
  8. Basic Science in Medical Education Clinical and Investigative Medicine, 22(1):23-24, February, 1999. MacLeod S.M.
  9. Building Uncertainty Into Cost-Effectiveness Rankings: portfolio risk-return trade-offs and implications for decision rules Medical Care (forthcoming). O'Brien BJ, Sculpher MJ.
  10. Can the Health Care System buy Better Antibiotic Prescribing Behaviour? Can Med Assoc J. 1999;160:1023-1024. Levine M, Pradhan A.
  11. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (forthcoming). Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon R, Mitchell B, Green M, Klein G, O'Brien B.
  12. Comparing the human capital approach and friction cost method for valuing productivity costs in schizophrenia. Canadian Journal of Psychiatry, 1999;44:455-463. Goeree R, Blackhouse G, Argo K, Goering P, O'Brien B.
  13. Current evidence on the cost-effectiveness of the implantable cardioverter defibrillator (CCS Consensus volume). Canadian Journal of Cardiology (forthcoming). O'Brien B, Yee R.
  14. Development, Dissemination, Implementation and Evaluation of a clinical pathway for Oxygen Therapy Canadian Medical Association Journal (forthcoming). Wong C, Visram F, Cook D, Griffith L, Randall J, O'Brien B, Higgins D.
  15. Diagnosis and management of acute alcohol withdrawal. CMAJ 1999;160:675-84. Holbrook AM, Crowther R, Lotter A, Cheng C, King D.
  16. Does Strengthening the Abdominal Muscles Prevent Low Back Pain - A Randomized Controlled Trial. J Rheumatol 1999;26(8):1808-1815. Helewa A, Goldsmith CH, Lee P, Smythe HA, Forwell L
  17. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. Am J Respir Crit Care Med 1999;160:1711-6. Labiris NRC, Holbrook AM, Chrystyn H, MacLeod S, Newhouse MT.
  18. Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. Journal of the American Geriatrics Society, 1999;47(5):570-578. O'Brien BJ, Goeree R, Hux M., Iskedjian M, Blackhouse G, Gagnon M, Gauthier S.
  19. Economic evaluation of long term management strategies for erosive oesophagitis. Pharmacoeconomics, 1999;16(6):679-697. Goeree R, O'Brien B, Hunt R, Blackhouse G, Willan A, Watson J.
  20. Economic evaluation of outpatient treatment with low molecular weight heparin for proximal vein thrombosis. Archives of Internal Medicine 1999;159:2298-2304 O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M. (view article)
  21. Electronic medical records in family practice: What drives physician interest and how much are they willing to pay? Medical Records Institute;Proceedings of Toward an Electronic Patient Record'98(Vol 3):30-3. Keshavjee K, Kyba R, Naisbitt R, Holbrook AM.
  22. Evaluating the Impact of Reference-based pricing [editorial]. Can Med Assoc J. 1999;161:273-4. Grootendorst P, Holbrook AM.
  23. Evidence-based EMR Software Selection: The COMPETE Study. Medical Records Institute;Proceedings of Toward an Electronic Patient Record'98(Vol 2):51-4. A Holbrook, K Langton, K Keshavjee, S Troyan and P Ford.
  24. Health care professionals' familiarity with non-pharmacological strategies for managing cancer pain. Pscyco-Oncology 8:99-111. 1999 Zaza C, Selleck SM, Willan AR, Reyno L, Browman GP.
  25. Holistic versus composite preferences for lifetime treatment sequences for type 2 diabetes. Medical Decision Making, 1999;19:113-121. MacKeigan LD, O'Brien BJ, Oh PI.
  26. Income effects of reduced health and health effects of reduced income: implications for health state valuation. Medical Decision Making (forthcoming). Sculpher MJ, O'Brien BJ.
  27. Interpreting meta-analyses of pharmacologic interventions: The pitfalls and how to identify them. Pharmacotherapy 1999;19:741-745. Etminan M, Levine M.
  28. Is the use of low-molecular-weight heparin in acute coronary syndrome patients cost saving in Canada? American Heart Journal (forthcoming). O'Brien B, Willan A, Blackhouse G, Goeree R, Cohen M, Goodman S.
  29. Lung Volume Reduction for Emphysema and the Canadian Lung Volume Reduction Surgery (CLVR) Project. Can Respir J 1999;6(1):26-32. Miller JD, Malthaner R, Goldsmith CH, Cox G, Higgins D, Stubbing DG, Kitching A, Newman TE, McDonald E
  30. Mastectomy or lumpectomy? Helping women make informed choices. Journal of Clinical Oncology 17:1727-1735. 1999 Whelan T, Levine M, Gafni A, Sanders K, Willan AR, Mirsky D, Schnider D, McCready D, Reid S, Kobylecky A, Reed K.
  31. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999;160:649-58. Holbrook AM, Crowther R, Lotter A, Cheng C, King D.
  32. Promoting optimal therapy for otitis media using commercially sponsored evidence-based detailing: a prospective controlled trial. Drug Information Journal 1999;33:1067-1077. Dolovich LR, Levine MAH, Tarajos R, Duku E.
  33. Report of the OMERACT Task Force on economic evaluation. Journal of Rheumatology, 1999;26:203-6. Gabriel S, Tugwell P, O'Brien B, Yelin E, Drummond M, et al.
  34. Risk of a new benzodiazepine prescription in relation to recent hospitalization. J Am Geriat Soc. 1999;47:184-8. Grad R, Tamblyn R, Holbrook AM, Hurley J, Feightner J, Gayton D.
  35. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. Health Economics, 1999;8:203-11. Willan A, O'Brien B.
  36. Statistical analysis of cost-effectiveness data. Journal of Rheumatology 1999 Oct;26(10):2078-80. O'Brien B.
  37. Successfully Implementing EMRs In Small Primary Care Physicians' Offices TEPR 1999 Conference Proceedings Vol. 1 587-591. Troyan S, Holbrook AM, Keshavjee KK, Langton K, Mazer A.
  38. The Ontario Prehospital Advanced Life Support (OPALS) study Part II: Rationale and methodology for trauma and respiratory distress patients. OPALS study group. Ann. Emerg. Med, 1999;34(2):256-62. Stiell IG, Wells GA, Spaite DW, Nichol G, O'Brien B, Munkley DP et al.
  39. The economic burden of schizophrenia in Canada. Canadian Journal of Psychiatry, 1999;44:464-472. Goeree R, O'Brien B, Goering P, Blackhouse G, Watson J.
  40. The role of research evidence in pharmaceutical policy making: evidence when necessary but not necessarily evidence Journal of Evaluation in Clinical Practice, 5(3):1-7, February, 1999. Willison, D., MacLeod, S.M.
  41. Therapeutic Equivalence: All studies are not created equal. Can J Clin Pharmacol 1999;6:9-11. Hatala R, Holbrook AM, Goldsmith CH.
  42. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. Can J Cardiol 1998;14:695-702. CQIN Investigators.
  43. Use of venous thromboembolism prophylaxis following total hip or knee arthroplasty: A survey of Canadian Orthopedic Surgeons. Canadian Journal of Surgery (forthcoming). Gross M, Anderson DR, Nagpal S, O'Brien B.
  44. Willingness to pay and the valuation of programmes for the prevention and control of influenza. Pharmacoeconomics, 1999;16 Suppl.1:55-61 Birch S, Gafni A, O'Brien B.
Toronto Web Design by LinxSmart
Graphic Design by Electra